Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The hemostats market is experiencing robust growth, driven by expanding surgical procedures and advancements in medical technology. As healthcare systems continue to develop, the demand for effective blood loss control tools is rising steadily. This overview explores the current market size, key growth drivers, emerging trends, leading companies, and regional dynamics shaping the future of the hemostats industry.

Hemostats Market Size and Expected Growth Through 2030

The hemostats market has witnessed significant expansion in recent years, with its value projected to rise from $3.56 billion in 2025 to $3.8 billion in 2026, reflecting a healthy compound annual growth rate (CAGR) of 6.7%. This growth owes much to the increasing number of surgical operations, improvements in hospital surgical infrastructure, advancements in biomaterial technologies, and the growing need for efficient blood management techniques during surgery. Additionally, the adoption of minimally invasive surgical approaches is further contributing to market expansion.

Looking ahead, the market is forecasted to reach $5.02 billion by 2030, maintaining an even stronger CAGR of 7.2%. Factors propelling this future growth include heightened emphasis on patient safety, increased demand for faster recovery post-surgery, the growth of specialized trauma care centers, ongoing innovations in bioactive hemostatic materials, and the rising use of specialized surgical products. Key trends set to influence the market encompass greater utilization of advanced combination hemostats, growing preference for ready-to-use hemostatic agents, demand for faster bleeding control solutions, expansion of biocompatible and absorbable materials, and a sharpened focus on surgical safety and efficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8226&type=smp

Increasing Volume of Surgical Procedures Promotes Hemostats Market Expansion

The continued rise in surgical interventions plays a vital role in driving the demand for hemostats. Surgical procedures broadly include all invasive treatments performed to diagnose or address medical conditions. Hemostats are indispensable in these operations, as they help control blood loss and maintain a clear surgical field.

For instance, data released in June 2024 by the American Society of Plastic Surgeons highlights a 7% increase in minimally invasive procedures in 2023, surpassing the overall growth rate of surgical interventions by 2%. Hand surgeries addressing conditions like carpal tunnel syndrome, arthritis, and trigger finger reached 207,887 procedures—a 2% rise compared to 2022. This upward trend in surgical volume directly stimulates demand for effective hemostatic devices.

Rising Trauma Cases Due to Road Accidents Fuel Hemostats Market Growth

Another significant factor propelling the hemostats market is the escalating number of trauma cases, particularly those resulting from road traffic accidents. Trauma refers to injuries caused by external forces that require immediate medical attention and intervention.

The increase in traffic density and unsafe driving behaviors contribute to more severe injuries, which necessitate rapid bleeding control to stabilize patients. Hemostats are critical in these emergency scenarios, enabling clinicians to quickly manage blood loss and improve survival rates. For example, statistics from October 2024, provided by the Alaska Department of Health, reveal that in 2023 approximately 3,373 individuals in Alaska suffered traumatic brain injuries, including both fatal and non-fatal cases treated in hospitals or emergency departments. Such data underscores how rising trauma incidents are boosting hemostats market demand.

Access The Complete Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Detailed Segmentation Offers Insight Into the Hemostats Market Structure

This report segments the hemostats market comprehensively as follows:

By Composition: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats

By Product Type: Active Hemostats, Passive Hemostats, Combination Hemostats, Other Related Products

By Formulation: Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats

By Application Area: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Other Applications

Further subcategories include topical and lyophilized thrombin within thrombin-based hemostats; pads and granules among oxidized regenerated cellulose varieties; thrombin combined with gelatin or collagen for combination types; gel foam and gelatin sponge for gelatin-based products; and collagen sheets and powders under collagen-based hemostats.

Collaborations and Partnerships Driving Innovation in the Hemostats Market

Leading players in the hemostats industry are increasingly forming strategic alliances and partnerships with startups and mid-sized companies to diversify their product ranges and strengthen their market presence. Such collaborations enable companies to expand geographically and introduce innovative solutions faster.

For example, in May 2023, Olympus, a Japan-based manufacturer specializing in optics and reprography, extended its partnership with US-based medical device company Endoclot to launch new hemostatic agents. This collaboration is geared toward improving patient outcomes during gastrointestinal procedures, raising the overall standard of care through safer treatment options.

Top Companies Shaping the Hemostats Market Landscape

The hemostats market is dominated by several prominent firms, including B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom’up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, and Anika Therapeutics Inc. These companies collectively drive technological advances and market expansion worldwide.

Regional Market Insights Highlighting Hemostats Industry Growth

In 2025, North America accounted for the largest share of the hemostats market, supported by strong healthcare infrastructure and technological advancement. Meanwhile, the Asia-Pacific region is poised to emerge as the fastest-growing market throughout the forecast period, driven by increasing healthcare investments and rising surgical volumes. The analysis covers key geographies such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa to provide a global perspective on market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model